{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,8]],"date-time":"2026-06-08T22:25:49Z","timestamp":1780957549612,"version":"3.54.1"},"reference-count":28,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2015,8,1]],"date-time":"2015-08-01T00:00:00Z","timestamp":1438387200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"name":"Consolidaci\u00f3n de Grupos UAM-CAM","award":["1004040047"],"award-info":[{"award-number":["1004040047"]}]},{"name":"Proyectos de Investigaci\u00f3n en Salud","award":["PI13\/00789"],"award-info":[{"award-number":["PI13\/00789"]}]},{"DOI":"10.13039\/501100007170","name":"Ministry of Economy","doi-asserted-by":"crossref","award":["AP2009\/0343"],"award-info":[{"award-number":["AP2009\/0343"]}],"id":[{"id":"10.13039\/501100007170","id-type":"DOI","asserted-by":"crossref"}]},{"name":"Universidad Autonoma de Madrid","award":["FPI-UAM2012"],"award-info":[{"award-number":["FPI-UAM2012"]}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Neuropharmacology"],"published-print":{"date-parts":[[2015,8]]},"DOI":"10.1016\/j.neuropharm.2015.02.016","type":"journal-article","created":{"date-parts":[[2015,4,20]],"date-time":"2015-04-20T22:25:03Z","timestamp":1429568703000},"page":"503-510","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":23,"special_numbering":"C","title":["Benzothiazepine CGP37157 and its 2\u2032-isopropyl analogue modulate Ca2+ entry through CALHM1"],"prefix":"10.1016","volume":"95","author":[{"given":"Ana J.","family":"Moreno-Ortega","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Francisco J.","family":"Mart\u00ednez-Sanz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Roc\u00edo","family":"Lajar\u00edn-Cuesta","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6456-7589","authenticated-orcid":false,"given":"Crist\u00f3bal","family":"de los Rios","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mar\u00eda F.","family":"Cano-Abad","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.neuropharm.2015.02.016_bib1","doi-asserted-by":"crossref","first-page":"334","DOI":"10.1111\/j.1749-6632.2003.tb07541.x","article-title":"Mitochondria as a target for neurotoxins and neuroprotective agents","volume":"993","author":"Bachurin","year":"2003","journal-title":"Ann. N. Y. Acad. Sci."},{"key":"10.1016\/j.neuropharm.2015.02.016_bib2","doi-asserted-by":"crossref","first-page":"407","DOI":"10.4161\/pri.20785","article-title":"Genetic variability of the gene cluster CALHM 1-3 in sporadic Creutzfeldt-Jakob disease","volume":"6","author":"Calero","year":"2012","journal-title":"Prion"},{"key":"10.1016\/j.neuropharm.2015.02.016_bib3","doi-asserted-by":"crossref","first-page":"155","DOI":"10.3233\/JAD-130872","article-title":"Evidence for the efficacy of latrepirdine (Dimebon) treatment for improvement of cognitive function: a meta-analysis","volume":"38","author":"Cano-Cuenca","year":"2014","journal-title":"J.\u00a0Alzheimers Dis."},{"key":"10.1016\/j.neuropharm.2015.02.016_bib4","doi-asserted-by":"crossref","first-page":"4399","DOI":"10.1016\/0006-2952(88)90623-5","article-title":"Structural dependency of the inhibitory action of benzodiazepines and related compounds on the mitochondrial Na+-Ca2+ exchanger","volume":"37","author":"Chiesi","year":"1988","journal-title":"Biochem. Pharmacol."},{"key":"10.1016\/j.neuropharm.2015.02.016_bib5","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1016\/j.ceca.2008.01.007","article-title":"Bcl2 mitigates Ca2+ entry and mitochondrial Ca2+ overload through downregulation of L-type Ca2+ channels in PC12 cells","volume":"44","author":"Diaz-Prieto","year":"2008","journal-title":"Cell Calcium"},{"key":"10.1016\/j.neuropharm.2015.02.016_bib6","doi-asserted-by":"crossref","first-page":"1149","DOI":"10.1016\/j.cell.2008.05.048","article-title":"A\u00a0polymorphism in CALHM1 influences Ca2+ homeostasis, Abeta levels, and Alzheimer's disease risk","volume":"133","author":"Dreses-Werringloer","year":"2008","journal-title":"Cell"},{"key":"10.1016\/j.neuropharm.2015.02.016_bib7","doi-asserted-by":"crossref","first-page":"1199","DOI":"10.1242\/jcs.117135","article-title":"CALHM1 controls Ca2+-dependent MEK\/ERK\/RSK\/MSK signaling in neurons","volume":"126","author":"Dreses-Werringloer","year":"2013","journal-title":"J.\u00a0Cell Sci."},{"key":"10.1016\/j.neuropharm.2015.02.016_bib8","doi-asserted-by":"crossref","first-page":"298","DOI":"10.1002\/mrc.1270060513","article-title":"Carbon-13-hydrogen coupling constants. III. Conformation dependence of 1J(13CH) fo r the formyl proton in aromatic aldehydes","volume":"6","author":"Ewing","year":"1974","journal-title":"Org. Magn. Reson."},{"key":"10.1016\/j.neuropharm.2015.02.016_bib9","doi-asserted-by":"crossref","first-page":"469","DOI":"10.1042\/BJ20110479","article-title":"Calcium homoeostasis modulator 1 (CALHM1) reduces the calcium content of the endoplasmic reticulum (ER) and triggers ER stress","volume":"437","author":"Gallego-Sandin","year":"2011","journal-title":"Biochem. J."},{"key":"10.1016\/j.neuropharm.2015.02.016_bib10","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1016\/j.neulet.2009.12.011","article-title":"CALHM1 P86L polymorphism does not alter amyloid-beta or tau in cerebrospinal fluid","volume":"469","author":"Giedraitis","year":"2010","journal-title":"Neurosci. Lett."},{"key":"10.1016\/j.neuropharm.2015.02.016_bib11","doi-asserted-by":"crossref","first-page":"519","DOI":"10.1021\/cn300009e","article-title":"Benzothiazepine CGP37157 and its Isosteric 2\u2032-methyl analogue provide neuroprotection and block cell calcium entry","volume":"3","author":"Gonzalez-Lafuente","year":"2012","journal-title":"ACS Chem. Neurosci."},{"key":"10.1016\/j.neuropharm.2015.02.016_bib12","doi-asserted-by":"crossref","first-page":"532","DOI":"10.1002\/ajmg.b.31014","article-title":"The P86L common allele of CALHM1 does not influence risk for Alzheimer disease in Japanese cohorts","volume":"153B","author":"Inoue","year":"2010","journal-title":"Am. J. Med. Genet. B Neuropsychiatr. Genet."},{"key":"10.1016\/j.neuropharm.2015.02.016_bib13","doi-asserted-by":"crossref","first-page":"974","DOI":"10.2119\/molmed.2011.00154","article-title":"CALHM1 P86L polymorphism modulates CSF Abeta levels in cognitively healthy individuals at risk for Alzheimer's disease","volume":"17","author":"Koppel","year":"2011","journal-title":"Mol. Med."},{"key":"10.1016\/j.neuropharm.2015.02.016_bib14","doi-asserted-by":"crossref","first-page":"247","DOI":"10.3233\/JAD-2010-100933","article-title":"The CALHM1 P86L polymorphism is a genetic modifier of age at onset in Alzheimer's disease: a meta-analysis study","volume":"22","author":"Lambert","year":"2010","journal-title":"J.\u00a0Alzheimers Dis."},{"key":"10.1016\/j.neuropharm.2015.02.016_bib15","doi-asserted-by":"crossref","first-page":"1079","DOI":"10.1023\/A:1017972709652","article-title":"Dimebon and tacrine inhibit neurotoxic action of beta-amyloid in culture and block L-type Ca(2+) channels","volume":"132","author":"Lermontova","year":"2001","journal-title":"Bull. Exp. Biol. Med."},{"key":"10.1016\/j.neuropharm.2015.02.016_bib16","doi-asserted-by":"crossref","first-page":"681","DOI":"10.1016\/j.yebeh.2011.02.007","article-title":"A\u00a0polymorphism in CALHM1 is associated with temporal lobe epilepsy","volume":"20","author":"Lv","year":"2011","journal-title":"Epilepsy Behav."},{"key":"10.1016\/j.neuropharm.2015.02.016_bib17","doi-asserted-by":"crossref","first-page":"E1963","DOI":"10.1073\/pnas.1204023109","article-title":"Calcium homeostasis modulator 1 (CALHM1) is the pore-forming subunit of an ion channel that mediates extracellular Ca2+ regulation of neuronal excitability","volume":"109","author":"Ma","year":"2012","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.neuropharm.2015.02.016_bib18","doi-asserted-by":"crossref","first-page":"588","DOI":"10.1042\/bj1040588","article-title":"Acid-base titration across the membrane system of rat-liver mitochondria. Catalysis by uncouplers","volume":"104","author":"Mitchell","year":"1967","journal-title":"Biochem. J."},{"key":"10.1016\/j.neuropharm.2015.02.016_bib19","doi-asserted-by":"crossref","first-page":"722","DOI":"10.1016\/j.bbrc.2009.11.127","article-title":"Mitochondria sense with different kinetics the calcium entering into HeLa cells through calcium channels CALHM1 and mutated P86L-CALHM1","volume":"391","author":"Moreno-Ortega","year":"2010","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.neuropharm.2015.02.016_bib20","doi-asserted-by":"crossref","first-page":"844","DOI":"10.1124\/jpet.109.154765","article-title":"Mitochondrial Na+\/Ca2+-exchanger blocker CGP37157 protects against chromaffin cell death elicited by veratridine","volume":"330","author":"Nicolau","year":"2009","journal-title":"J.\u00a0Pharmacol. Exp. Ther."},{"key":"10.1016\/j.neuropharm.2015.02.016_bib21","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1016\/j.bbrc.2010.08.028","article-title":"Mitochondrial Na+\/Ca2+ exchanger, a new target for neuroprotection in rat hippocampal slices","volume":"400","author":"Nicolau","year":"2010","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.neuropharm.2015.02.016_bib22","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1021\/jo020446t","article-title":"Efficient syntheses of benzothiazepines as antagonists for the mitochondrial sodium-calcium exchanger: potential therapeutics for type II diabetes","volume":"68","author":"Pei","year":"2003","journal-title":"J.\u00a0Org. Chem."},{"key":"10.1016\/j.neuropharm.2015.02.016_bib23","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1111\/apha.12027","article-title":"Energetic study of cardioplegic hearts under ischaemia\/reperfusion and [Ca(2+)] changes in cardiomyocytes of guinea-pig: mitochondrial role","volume":"207","author":"Ragone","year":"2013","journal-title":"Acta Physiol. (Oxf.)"},{"key":"10.1016\/j.neuropharm.2015.02.016_bib24","doi-asserted-by":"crossref","first-page":"11350","DOI":"10.1021\/ja303443m","article-title":"Outer-sphere direction in iridium C-H borylation","volume":"134","author":"Roosen","year":"2012","journal-title":"J.\u00a0Am. Chem. Soc."},{"key":"10.1016\/j.neuropharm.2015.02.016_bib25","doi-asserted-by":"crossref","first-page":"12275","DOI":"10.1523\/JNEUROSCI.5919-12.2013","article-title":"CLHM-1 is a functionally conserved and conditionally toxic Ca2+-permeable ion channel in Caenorhabditis elegans","volume":"33","author":"Tanis","year":"2013","journal-title":"J.\u00a0Neurosci."},{"issue":"1956","key":"10.1016\/j.neuropharm.2015.02.016_bib26","first-page":"e1913","article-title":"Lack of association between CALHM1\u00a0p.P86L variation and Alzheimer's disease in the Han Chinese population","volume":"35","author":"Tao","year":"2014","journal-title":"Neurobiol. Aging"},{"key":"10.1016\/j.neuropharm.2015.02.016_bib27","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1038\/nature11906","article-title":"CALHM1 ion channel mediates purinergic neurotransmission of sweet, bitter and umami tastes","volume":"495","author":"Taruno","year":"2013","journal-title":"Nature"},{"key":"10.1016\/j.neuropharm.2015.02.016_bib28","doi-asserted-by":"crossref","first-page":"515","DOI":"10.1093\/chemse\/bju020","article-title":"Salty taste deficits in CALHM1 knockout mice","volume":"39","author":"Tordoff","year":"2014","journal-title":"Chem. Senses"}],"container-title":["Neuropharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0028390815000635?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0028390815000635?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,8,23]],"date-time":"2019-08-23T17:15:24Z","timestamp":1566580524000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0028390815000635"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,8]]},"references-count":28,"alternative-id":["S0028390815000635"],"URL":"https:\/\/doi.org\/10.1016\/j.neuropharm.2015.02.016","relation":{},"ISSN":["0028-3908"],"issn-type":[{"value":"0028-3908","type":"print"}],"subject":[],"published":{"date-parts":[[2015,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Benzothiazepine CGP37157 and its 2\u2032-isopropyl analogue modulate Ca2+ entry through CALHM1","name":"articletitle","label":"Article Title"},{"value":"Neuropharmacology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.neuropharm.2015.02.016","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2015 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}